# A Second Trial of the Abbreviated Protocol Two-Stage Exchange

> **NCT05607030** · PHASE2 · COMPLETED · sponsor: **Osteal Therapeutics, Inc.** · enrollment: 76 (actual)

## Conditions studied

- Prosthetic-joint Infection

## Interventions

- **COMBINATION_PRODUCT:** VT-X7 Treatment System
- **PROCEDURE:** Two-stage exchange arthroplasty
- **DRUG:** SOC Antibiotics
- **DRUG:** Experimental Antibiotics

## Key facts

- **NCT ID:** NCT05607030
- **Lead sponsor:** Osteal Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-23
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-10-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607030, "A Second Trial of the Abbreviated Protocol Two-Stage Exchange". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05607030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*